Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data

Will Chou (South San Francisco, United States of America), Michael Broder, Eunice Change, Elya Papoyan, Iona Popescu, Sheila Reddy, Karina Raimundo, Will Chou

Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Session: Burden of respiratory diseases: from environmental aspects to healthcare consumption
Session type: Poster Discussion
Number: 4919
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Will Chou (South San Francisco, United States of America), Michael Broder, Eunice Change, Elya Papoyan, Iona Popescu, Sheila Reddy, Karina Raimundo, Will Chou. Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data. Eur Respir J 2016; 48: Suppl. 60, 4919

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
Source: International Congress 2016 – IPF clinical
Year: 2016

Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016

Source of referral and other factors affecting readmission for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015


Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013

Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone
Source: International Congress 2016 – Orphan diseases II
Year: 2016

Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016


Mortality associated with the type of heart failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016